Business
Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 July 2025
Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 1 of the private placement amounted to 4,731,594 shares. As disclosed separately, Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, participated in the private placement and subscribed for 739,360 shares in Tranche 1. In connection wit
About this update from Idex Biometrics Asa
[{"type":"image","alt":"IDEX BIOMETRICS ASA","displaySize":"","headline":null,"caption":"IDEX BIOMETRICS ASA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":99,"url":"https://media.zenfs.com/en/globenewswire.com/e9861ff864a1550fbbb308e020c27552"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/06iRU0u2vX7ltcONxES.qA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e9861ff864a1550fbbb308e020c27552","width":300,"height":99}},"lazy":false},{"type":"text","content":"Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.","length":230,"tagName":"p"},{"type":"text","content":"Tranche 1 of the private placement amounted to 4,731,594 shares. As disclosed separately, Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, participated in the private placement and subscribed for 739,360 shares in Tranche 1.","length":251,"tagName":"p"},{"type":"text","content":"In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement.","length":154,"tagName":"p"},{"type":"text","content":"Mr. Storbråten has lent 4,731,594 shares, ISIN NO0013536078, in connection with the settlement of Tranche 1. The shares have been lent, not sold, and will be returned in due course.","length":181,"tagName":"p"},{"type":"text","content":"After the subscription by Pinchcliffe and the temporary lending of shares, Mr. Storbråten and close relations hold 6,503,476 or 12,48% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 1.","length":233,"tagName":"p"},{"type":"text","content":"Contact personAnders Storbråten, CEO and CFO Tel: +47 4163 8582E-mail: [email protected]","length":95,"tagName":"p"},{"type":"text","content":"About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated ...